CIK: 0001792206 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $164,403 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NTRA | Natera, Inc. | 67,356 | $15,431 | 9.4% | $208.59 | 0.0% | COM | 632307104 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ALMS | ALUMIS INC. | 5,779,348 | $56,406 | 34.3% | $13.19 | -47.1% | COM | 022307102 |
| LYEL | Lyell Immunopharma, Inc. | 477,078 | $14,684 | 8.9% | $9.45 | +136.7% | COM | 55083R203 |
| HIMS | Hims & Hers Health, Inc. | 273,151 | $8,869 | 5.4% | $8.41 | +409.5% | COM CL A | 433000106 |
| IRON | Disc Medicine, Inc. | 299,069 | $23,749 | 14.4% | $46.85 | +80.4% | COM | 254604101 |
| MAZE | Maze Therapeutics, Inc. | 86,291 | $3,575 | 2.2% | $12.04 | +185.5% | COM | 578784100 |
| CGON | CG Oncology, Inc. | 1,004,050 | $41,688 | 25.4% | $36.31 | +14.0% | COM | 156944100 |